Yisheng Biopharma Co., Ltd.’s US$40 Million Royalty-Backed Financing From R-Bridge Healthcare Fund

Clifford Chance has advised Yisheng Biopharma Co., Ltd. on the deal, while Sidley Austin LLP and Maples and Calder advised R-Bridge Healthcare Fund.Yisheng Biopharma Co., Ltd….

This content is for Standard 1 Year members only.
Login Join Now
Giulia Di Palma

Author: Giulia Di Palma

This content is for Standard 1 Year members only.
Login Join Now